China Sanjiang Fine Chemicals Company Limited (HKG:2198) shares have had a really impressive month, gaining 35% after a shaky period beforehand. The bad news is that even after the stocks recovery in the last 30 days, shareholders are still underwater by about 9.3% over the last year.
Even after such a large jump in price, it's still not a stretch to say that China Sanjiang Fine Chemicals' price-to-sales (or "P/S") ratio of 0.2x right now seems quite "middle-of-the-road" compared to the Chemicals industry in Hong Kong, where the median P/S ratio is around 0.3x. While this might not raise any eyebrows, if the P/S ratio is not justified investors could be missing out on a potential opportunity or ignoring looming disappointment.
How Has China Sanjiang Fine Chemicals Performed Recently?
For example, consider that China Sanjiang Fine Chemicals' financial performance has been poor lately as its revenue has been in decline. One possibility is that the P/S is moderate because investors think the company might still do enough to be in line with the broader industry in the near future. If you like the company, you'd at least be hoping this is the case so that you could potentially pick up some stock while it's not quite in favour.
Although there are no analyst estimates available for China Sanjiang Fine Chemicals, take a look at this free data-rich visualisation to see how the company stacks up on earnings, revenue and cash flow.
What Are Revenue Growth Metrics Telling Us About The P/S?
There's an inherent assumption that a company should be matching the industry for P/S ratios like China Sanjiang Fine Chemicals' to be considered reasonable.
Retrospectively, the last year delivered a frustrating 11% decrease to the company's top line. This means it has also seen a slide in revenue over the longer-term as revenue is down 2.7% in total over the last three years. Therefore, it's fair to say the revenue growth recently has been undesirable for the company.
In contrast to the company, the rest of the industry is expected to grow by 4.5% over the next year, which really puts the company's recent medium-term revenue decline into perspective.
With this information, we find it concerning that China Sanjiang Fine Chemicals is trading at a fairly similar P/S compared to the industry. It seems most investors are ignoring the recent poor growth rate and are hoping for a turnaround in the company's business prospects. Only the boldest would assume these prices are sustainable as a continuation of recent revenue trends is likely to weigh on the share price eventually.
The Key Takeaway
Its shares have lifted substantially and now China Sanjiang Fine Chemicals' P/S is back within range of the industry median. We'd say the price-to-sales ratio's power isn't primarily as a valuation instrument but rather to gauge current investor sentiment and future expectations.
The fact that China Sanjiang Fine Chemicals currently trades at a P/S on par with the rest of the industry is surprising to us since its recent revenues have been in decline over the medium-term, all while the industry is set to grow. When we see revenue heading backwards in the context of growing industry forecasts, it'd make sense to expect a possible share price decline on the horizon, sending the moderate P/S lower. Unless the recent medium-term conditions improve markedly, investors will have a hard time accepting the share price as fair value.
Before you take the next step, you should know about the 2 warning signs for China Sanjiang Fine Chemicals that we have uncovered.
If you're unsure about the strength of China Sanjiang Fine Chemicals' business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.
Have feedback on this article? Concerned about the content?Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
China Sanjiang Fine Chemicals(HKG:2198)の株式は、前に不安定な期間があった後、非常に印象的な1か月間で35%上昇しました。悪いニュースは、過去1年間において、株主は株価の回復後でも約9.3%の下水にあります。
価格が大きく上昇したとしても、現在のChina Sanjiang Fine Chemicalsの売上高(または「P / S」)比率が0.2倍であることは、香港の化学産業の中央値の0.3倍に比べてかなり「中庸」と言えると思われます。これによってまゆをひそめることはできますが、P / S比が正当化されていない場合、投資家は潜在的な機会を逸する可能性があるか、迫りくる失望を無視してしまう可能性があります。
中国三江精細化工の最近のパフォーマンスはどのようになっていますか?
例えば、China Sanjiang Fine Chemicalsの財務パフォーマンスが最近低迷しており、売上高が減少していることを考慮してください。1つの可能性は、P / Sがそのままである理由は、投資家が会社が近い将来に業界全体と同じくらいのことをすると考えているためかもしれないということです。この会社が好きなら、少なくとも好調ではない間、ストックを購入する可能性があることを望んでいます。
China Sanjiang Fine Chemicalsに対するアナリストの予想はありませんが、この無料のデータ豊富な可視化を見て、同社の収益、売上高、キャッシュフローがどのように比較されるかを確認してください。
売上高成長メトリックスはP / Sについてどのように話しているのでしょうか?
China Sanjiang Fine ChemicalsのようなP / S比率で業界に追随することが、妥当と見なされるべき前提があります。
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会(ASIC)の管理を受けております(AFSL No. 224663)。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。
オーストラリアでは、moomooの投資商品及びサービスはMoomoo Securities Australia Limitedによって提供され、オーストラリア証券投資委員会(ASIC)の管理を受けております(AFSL No. 224663)。「金融サービスガイド」、「利用規約」、「プライバシーポリシー」などの詳細は、Moomoo Securities Australia Limitedのウェブサイトhttps://www.moomoo.com/auでご確認いただけます。